| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nerve Tissue Proteins | 7 | 2019 | 521 | 2.030 |
Why?
|
| Laminin | 14 | 2002 | 89 | 1.700 |
Why?
|
| Lung | 20 | 2014 | 1408 | 1.480 |
Why?
|
| Lymphangioleiomyomatosis | 5 | 2016 | 8 | 1.420 |
Why?
|
| Oncogene Proteins | 4 | 2019 | 66 | 1.360 |
Why?
|
| Muscle, Smooth | 10 | 2008 | 299 | 1.280 |
Why?
|
| Fibroblasts | 9 | 2019 | 766 | 1.190 |
Why?
|
| Transforming Growth Factor beta | 5 | 2016 | 357 | 1.100 |
Why?
|
| Mesoderm | 13 | 2002 | 122 | 1.020 |
Why?
|
| Transforming Growth Factor beta1 | 4 | 2019 | 94 | 0.650 |
Why?
|
| Serum Response Factor | 4 | 2004 | 42 | 0.640 |
Why?
|
| Muscle Development | 3 | 2008 | 39 | 0.590 |
Why?
|
| Transforming Growth Factor beta3 | 2 | 2019 | 12 | 0.580 |
Why?
|
| Exosomes | 1 | 2020 | 66 | 0.580 |
Why?
|
| Transforming Growth Factor beta2 | 2 | 2019 | 16 | 0.580 |
Why?
|
| Extracellular Vesicles | 1 | 2020 | 58 | 0.570 |
Why?
|
| Immunohistochemistry | 17 | 2016 | 1816 | 0.570 |
Why?
|
| Proteomics | 1 | 2020 | 279 | 0.530 |
Why?
|
| Protein Biosynthesis | 3 | 2019 | 393 | 0.510 |
Why?
|
| Pulmonary Fibrosis | 1 | 2019 | 158 | 0.490 |
Why?
|
| Myocytes, Smooth Muscle | 3 | 2013 | 135 | 0.490 |
Why?
|
| Endothelium, Lymphatic | 1 | 2016 | 11 | 0.480 |
Why?
|
| Bronchi | 5 | 2002 | 229 | 0.480 |
Why?
|
| Angiomyolipoma | 1 | 2016 | 15 | 0.480 |
Why?
|
| Mice | 33 | 2016 | 12718 | 0.470 |
Why?
|
| Cicatrix | 1 | 2016 | 78 | 0.470 |
Why?
|
| Wound Healing | 4 | 2018 | 384 | 0.470 |
Why?
|
| Cell Differentiation | 14 | 2008 | 1647 | 0.440 |
Why?
|
| Eukaryotic Initiation Factor-3 | 1 | 2014 | 4 | 0.430 |
Why?
|
| Proteins | 2 | 2020 | 803 | 0.430 |
Why?
|
| Animals | 46 | 2019 | 28950 | 0.420 |
Why?
|
| Carrier Proteins | 2 | 2008 | 668 | 0.400 |
Why?
|
| Endothelium | 1 | 2013 | 63 | 0.380 |
Why?
|
| Receptors, Progesterone | 1 | 2014 | 208 | 0.380 |
Why?
|
| Estrogen Receptor alpha | 1 | 2014 | 159 | 0.370 |
Why?
|
| Lymphatic Vessels | 1 | 2013 | 74 | 0.360 |
Why?
|
| Cell Size | 6 | 2008 | 71 | 0.350 |
Why?
|
| Epithelial Cells | 10 | 2001 | 710 | 0.350 |
Why?
|
| Cells, Cultured | 13 | 2013 | 2856 | 0.340 |
Why?
|
| Histone Acetyltransferases | 2 | 2008 | 45 | 0.330 |
Why?
|
| Bleomycin | 2 | 2019 | 102 | 0.330 |
Why?
|
| Homeostasis | 1 | 2013 | 474 | 0.330 |
Why?
|
| Basement Membrane | 5 | 1999 | 58 | 0.310 |
Why?
|
| Molecular Sequence Data | 9 | 2014 | 2894 | 0.300 |
Why?
|
| Antibiotics, Antineoplastic | 2 | 2016 | 111 | 0.300 |
Why?
|
| Blood Pressure | 1 | 2013 | 920 | 0.290 |
Why?
|
| Peptide Fragments | 2 | 2004 | 480 | 0.290 |
Why?
|
| Amino Acid Sequence | 7 | 2014 | 2003 | 0.290 |
Why?
|
| Respiratory System | 2 | 2008 | 120 | 0.290 |
Why?
|
| Collagen | 6 | 2019 | 313 | 0.280 |
Why?
|
| NIH 3T3 Cells | 4 | 2014 | 113 | 0.280 |
Why?
|
| Mice, Inbred C57BL | 5 | 2019 | 3612 | 0.280 |
Why?
|
| Protein Isoforms | 6 | 2008 | 303 | 0.280 |
Why?
|
| Nuclear Proteins | 2 | 2005 | 752 | 0.280 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2008 | 28 | 0.280 |
Why?
|
| Adipogenesis | 1 | 2008 | 46 | 0.270 |
Why?
|
| Proteoglycans | 3 | 1998 | 76 | 0.270 |
Why?
|
| rhoA GTP-Binding Protein | 2 | 2013 | 90 | 0.270 |
Why?
|
| Adipocytes | 2 | 2008 | 180 | 0.270 |
Why?
|
| Lung Neoplasms | 2 | 2014 | 2467 | 0.250 |
Why?
|
| Mice, Knockout | 3 | 2019 | 2209 | 0.250 |
Why?
|
| Mice, Inbred Strains | 9 | 2003 | 281 | 0.250 |
Why?
|
| Cell Proliferation | 3 | 2016 | 1790 | 0.250 |
Why?
|
| Stress, Mechanical | 3 | 2005 | 251 | 0.250 |
Why?
|
| Cell Movement | 4 | 2006 | 816 | 0.250 |
Why?
|
| Cell Polarity | 2 | 1998 | 122 | 0.240 |
Why?
|
| Blotting, Western | 4 | 2016 | 779 | 0.240 |
Why?
|
| Gene Expression Regulation | 5 | 2014 | 2020 | 0.230 |
Why?
|
| Organ Culture Techniques | 10 | 2001 | 120 | 0.230 |
Why?
|
| Humans | 44 | 2020 | 98223 | 0.230 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2016 | 301 | 0.220 |
Why?
|
| Myoblasts | 1 | 2005 | 34 | 0.220 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2004 | 49 | 0.210 |
Why?
|
| Extracellular Matrix | 6 | 2006 | 259 | 0.210 |
Why?
|
| Melanocytes | 1 | 2004 | 62 | 0.210 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2005 | 91 | 0.210 |
Why?
|
| Alternative Splicing | 3 | 2005 | 224 | 0.200 |
Why?
|
| Protein Precursors | 1 | 2004 | 133 | 0.200 |
Why?
|
| Lymphangiomyoma | 1 | 2003 | 1 | 0.200 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-3 | 1 | 2003 | 4 | 0.190 |
Why?
|
| RNA, Messenger | 7 | 2013 | 2068 | 0.190 |
Why?
|
| Recombinant Proteins | 4 | 2014 | 994 | 0.190 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2016 | 314 | 0.190 |
Why?
|
| Botulinum Toxins | 1 | 2002 | 16 | 0.180 |
Why?
|
| Culture Media, Conditioned | 3 | 2018 | 102 | 0.170 |
Why?
|
| Tensile Strength | 2 | 2016 | 88 | 0.170 |
Why?
|
| Embryo Implantation | 1 | 2000 | 24 | 0.160 |
Why?
|
| Epithelium | 8 | 2002 | 316 | 0.160 |
Why?
|
| Oligonucleotides, Antisense | 2 | 2001 | 66 | 0.160 |
Why?
|
| Trophoblasts | 1 | 2000 | 36 | 0.160 |
Why?
|
| Abortion, Habitual | 1 | 2000 | 31 | 0.160 |
Why?
|
| A549 Cells | 1 | 2020 | 53 | 0.160 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2018 | 207 | 0.150 |
Why?
|
| Tretinoin | 3 | 1999 | 130 | 0.150 |
Why?
|
| Transfection | 4 | 2006 | 883 | 0.150 |
Why?
|
| Cell Lineage | 2 | 2016 | 332 | 0.150 |
Why?
|
| Stem Cells | 1 | 2002 | 397 | 0.150 |
Why?
|
| Male | 20 | 2019 | 47195 | 0.140 |
Why?
|
| Morphogenesis | 6 | 1999 | 208 | 0.140 |
Why?
|
| Cell Adhesion | 7 | 2004 | 420 | 0.140 |
Why?
|
| DNA-Binding Proteins | 2 | 2004 | 1261 | 0.140 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2008 | 1395 | 0.140 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2016 | 373 | 0.140 |
Why?
|
| Low-Level Light Therapy | 1 | 2018 | 16 | 0.140 |
Why?
|
| Wound Infection | 1 | 2018 | 18 | 0.140 |
Why?
|
| Curcumin | 1 | 2018 | 18 | 0.140 |
Why?
|
| Coculture Techniques | 4 | 1999 | 175 | 0.140 |
Why?
|
| Platelet-Derived Growth Factor | 3 | 2004 | 65 | 0.140 |
Why?
|
| Heparin | 2 | 1996 | 182 | 0.130 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2000 | 244 | 0.130 |
Why?
|
| Protein Binding | 2 | 2014 | 1557 | 0.130 |
Why?
|
| Photosensitizing Agents | 1 | 2018 | 53 | 0.130 |
Why?
|
| Cell Division | 7 | 2004 | 690 | 0.130 |
Why?
|
| Hepatitis D | 2 | 1988 | 6 | 0.130 |
Why?
|
| Female | 22 | 2014 | 51685 | 0.130 |
Why?
|
| Rats | 8 | 2018 | 4073 | 0.130 |
Why?
|
| Growth Substances | 2 | 1996 | 79 | 0.130 |
Why?
|
| Down-Regulation | 3 | 2004 | 529 | 0.120 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 1990 | 709 | 0.120 |
Why?
|
| Computational Biology | 1 | 2020 | 615 | 0.120 |
Why?
|
| Antibodies, Monoclonal | 4 | 1998 | 1417 | 0.120 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2019 | 240 | 0.120 |
Why?
|
| Methyltransferases | 2 | 2008 | 220 | 0.110 |
Why?
|
| Mice, Inbred ICR | 3 | 2005 | 76 | 0.110 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 1996 | 197 | 0.110 |
Why?
|
| Glycoproteins | 1 | 1996 | 221 | 0.110 |
Why?
|
| Staphylococcal Infections | 1 | 2018 | 287 | 0.110 |
Why?
|
| Sirolimus | 1 | 2016 | 182 | 0.110 |
Why?
|
| Embryonic and Fetal Development | 4 | 2002 | 66 | 0.110 |
Why?
|
| 5' Untranslated Regions | 1 | 2014 | 52 | 0.110 |
Why?
|
| Protein Structure, Tertiary | 2 | 2008 | 731 | 0.110 |
Why?
|
| DNA | 1 | 2000 | 1274 | 0.110 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 2575 | 0.110 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2016 | 221 | 0.110 |
Why?
|
| Muscle Proteins | 3 | 2000 | 131 | 0.110 |
Why?
|
| Luciferases | 1 | 2014 | 128 | 0.110 |
Why?
|
| Signal Transduction | 2 | 2016 | 3627 | 0.100 |
Why?
|
| Case-Control Studies | 1 | 2019 | 2002 | 0.100 |
Why?
|
| Genes, Reporter | 1 | 2014 | 276 | 0.100 |
Why?
|
| Sequence Alignment | 1 | 2014 | 353 | 0.100 |
Why?
|
| Endothelium, Vascular | 4 | 1991 | 440 | 0.100 |
Why?
|
| Aortography | 1 | 2013 | 60 | 0.100 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2013 | 58 | 0.100 |
Why?
|
| Embryo, Mammalian | 3 | 2005 | 220 | 0.100 |
Why?
|
| Myxoma | 3 | 1989 | 28 | 0.100 |
Why?
|
| Hypotension | 1 | 2013 | 77 | 0.090 |
Why?
|
| Heart Neoplasms | 3 | 1989 | 52 | 0.090 |
Why?
|
| Phenotype | 3 | 2006 | 2653 | 0.090 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2013 | 234 | 0.090 |
Why?
|
| Muscle Contraction | 1 | 2013 | 269 | 0.090 |
Why?
|
| Dextrans | 2 | 2003 | 77 | 0.090 |
Why?
|
| Tumor Cells, Cultured | 7 | 2002 | 1028 | 0.090 |
Why?
|
| Aorta | 1 | 2013 | 275 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2004 | 889 | 0.090 |
Why?
|
| Binding Sites | 1 | 2014 | 1159 | 0.090 |
Why?
|
| Cell Line, Tumor | 2 | 2016 | 2894 | 0.090 |
Why?
|
| Escherichia coli | 1 | 2014 | 571 | 0.090 |
Why?
|
| Actins | 3 | 2004 | 480 | 0.090 |
Why?
|
| Up-Regulation | 1 | 2013 | 743 | 0.080 |
Why?
|
| Adult | 11 | 2014 | 29548 | 0.080 |
Why?
|
| ErbB Receptors | 1 | 1993 | 516 | 0.080 |
Why?
|
| Platelet Membrane Glycoproteins | 2 | 2004 | 18 | 0.080 |
Why?
|
| Hepatitis B | 2 | 1988 | 78 | 0.080 |
Why?
|
| Umbilical Veins | 1 | 1989 | 45 | 0.070 |
Why?
|
| Pregnancy | 5 | 2000 | 3266 | 0.070 |
Why?
|
| Gene Expression | 1 | 2013 | 1321 | 0.070 |
Why?
|
| Liver Neoplasms | 2 | 2002 | 826 | 0.070 |
Why?
|
| Matrix Metalloproteinase 14 | 1 | 2008 | 5 | 0.070 |
Why?
|
| Acetylation | 1 | 2008 | 150 | 0.070 |
Why?
|
| Floxuridine | 1 | 1988 | 11 | 0.070 |
Why?
|
| PPAR gamma | 1 | 2008 | 80 | 0.070 |
Why?
|
| Sequence Deletion | 1 | 2008 | 207 | 0.070 |
Why?
|
| Interferon-gamma | 1 | 1990 | 479 | 0.070 |
Why?
|
| Structure-Activity Relationship | 1 | 2008 | 426 | 0.070 |
Why?
|
| Duodenum | 1 | 1988 | 113 | 0.060 |
Why?
|
| Rats, Wistar | 2 | 2018 | 304 | 0.060 |
Why?
|
| Drug Combinations | 2 | 1998 | 201 | 0.060 |
Why?
|
| Histones | 2 | 2008 | 364 | 0.060 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2008 | 215 | 0.060 |
Why?
|
| Ki-67 Antigen | 2 | 2004 | 70 | 0.060 |
Why?
|
| Luteal Cells | 1 | 1986 | 2 | 0.060 |
Why?
|
| Corpus Luteum | 1 | 1986 | 14 | 0.060 |
Why?
|
| Ovarian Cysts | 1 | 1986 | 15 | 0.060 |
Why?
|
| Gastroenteritis | 1 | 1986 | 26 | 0.060 |
Why?
|
| ral GTP-Binding Proteins | 1 | 2006 | 2 | 0.060 |
Why?
|
| Intestinal Perforation | 1 | 1986 | 38 | 0.060 |
Why?
|
| Aged | 7 | 2013 | 21824 | 0.060 |
Why?
|
| Fluorescein-5-isothiocyanate | 2 | 1999 | 27 | 0.060 |
Why?
|
| Prostatic Neoplasms | 3 | 2004 | 1841 | 0.060 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 1991 | 1107 | 0.060 |
Why?
|
| Cross Reactions | 2 | 2000 | 116 | 0.060 |
Why?
|
| Skin | 3 | 2018 | 591 | 0.060 |
Why?
|
| Cell Nucleus | 3 | 2004 | 615 | 0.060 |
Why?
|
| Eosinophilia | 1 | 1986 | 87 | 0.060 |
Why?
|
| Intestinal Mucosa | 2 | 1988 | 842 | 0.060 |
Why?
|
| Ileum | 1 | 1986 | 178 | 0.060 |
Why?
|
| Liver Diseases | 1 | 1988 | 250 | 0.060 |
Why?
|
| Immunoblotting | 2 | 2000 | 273 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2000 | 1946 | 0.060 |
Why?
|
| Aged, 80 and over | 3 | 2013 | 7409 | 0.060 |
Why?
|
| Transcription, Genetic | 2 | 2008 | 1133 | 0.060 |
Why?
|
| Adipose Tissue | 1 | 2008 | 280 | 0.060 |
Why?
|
| Middle Aged | 8 | 2013 | 29494 | 0.060 |
Why?
|
| Acetyltransferases | 1 | 2005 | 35 | 0.060 |
Why?
|
| RNA Interference | 1 | 2006 | 388 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 1 | 2008 | 978 | 0.060 |
Why?
|
| Tetraspanin 30 | 1 | 2004 | 3 | 0.050 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2005 | 79 | 0.050 |
Why?
|
| Fibrinolysin | 1 | 2004 | 25 | 0.050 |
Why?
|
| Matrix Metalloproteinases | 1 | 2004 | 30 | 0.050 |
Why?
|
| Liver Cirrhosis | 1 | 1987 | 290 | 0.050 |
Why?
|
| Plasminogen | 1 | 2004 | 45 | 0.050 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2004 | 46 | 0.050 |
Why?
|
| Spleen | 2 | 2003 | 376 | 0.050 |
Why?
|
| Dermis | 1 | 2004 | 30 | 0.050 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2004 | 55 | 0.050 |
Why?
|
| Precipitin Tests | 1 | 2004 | 101 | 0.050 |
Why?
|
| Skin Aging | 1 | 2004 | 31 | 0.050 |
Why?
|
| Lymphokines | 1 | 2004 | 74 | 0.050 |
Why?
|
| Yeasts | 1 | 2004 | 50 | 0.050 |
Why?
|
| Mammary Neoplasms, Experimental | 2 | 2002 | 130 | 0.050 |
Why?
|
| Graft vs Leukemia Effect | 1 | 2003 | 11 | 0.050 |
Why?
|
| Lymphocyte Transfusion | 1 | 2003 | 39 | 0.050 |
Why?
|
| Leukemia, B-Cell | 1 | 2003 | 22 | 0.050 |
Why?
|
| Immunization | 1 | 2003 | 154 | 0.050 |
Why?
|
| Pressure | 1 | 2003 | 173 | 0.050 |
Why?
|
| Antigens, CD | 1 | 2004 | 484 | 0.050 |
Why?
|
| 3T3 Cells | 1 | 2002 | 94 | 0.050 |
Why?
|
| Genetic Vectors | 1 | 2004 | 426 | 0.050 |
Why?
|
| Plasmids | 1 | 2003 | 275 | 0.050 |
Why?
|
| Peptides | 2 | 1996 | 670 | 0.050 |
Why?
|
| ADP Ribose Transferases | 1 | 2002 | 7 | 0.040 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2002 | 31 | 0.040 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2002 | 30 | 0.040 |
Why?
|
| Cathepsins | 1 | 2002 | 22 | 0.040 |
Why?
|
| Cell Transplantation | 1 | 2002 | 46 | 0.040 |
Why?
|
| Graft vs Tumor Effect | 1 | 2002 | 26 | 0.040 |
Why?
|
| Endothelin-1 | 1 | 2002 | 42 | 0.040 |
Why?
|
| Serpins | 1 | 2001 | 31 | 0.040 |
Why?
|
| Lysophospholipids | 1 | 2002 | 67 | 0.040 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2001 | 49 | 0.040 |
Why?
|
| Cysteine Endopeptidases | 1 | 2002 | 89 | 0.040 |
Why?
|
| Calcium | 2 | 1999 | 1201 | 0.040 |
Why?
|
| Mammary Tumor Virus, Mouse | 1 | 2001 | 64 | 0.040 |
Why?
|
| Carcinoma in Situ | 1 | 2001 | 55 | 0.040 |
Why?
|
| Ribonucleoproteins | 1 | 2001 | 40 | 0.040 |
Why?
|
| Cell Communication | 2 | 2004 | 223 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2003 | 700 | 0.040 |
Why?
|
| Chorion | 1 | 2000 | 15 | 0.040 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2002 | 304 | 0.040 |
Why?
|
| Antibody Specificity | 1 | 2000 | 125 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 3 | 1991 | 310 | 0.040 |
Why?
|
| Desmin | 1 | 1999 | 10 | 0.040 |
Why?
|
| Muscular Dystrophy, Animal | 1 | 1999 | 21 | 0.040 |
Why?
|
| Digestive System | 1 | 1999 | 42 | 0.040 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2003 | 335 | 0.040 |
Why?
|
| Thionucleotides | 1 | 1999 | 54 | 0.040 |
Why?
|
| Fetus | 1 | 2000 | 238 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 1999 | 217 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 1999 | 29 | 0.040 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 85 | 0.040 |
Why?
|
| Neutrophils | 3 | 1989 | 346 | 0.040 |
Why?
|
| Myosins | 1 | 1999 | 89 | 0.040 |
Why?
|
| Autoantibodies | 1 | 2000 | 286 | 0.040 |
Why?
|
| Microscopy, Electron | 3 | 2004 | 435 | 0.040 |
Why?
|
| Cell Line | 1 | 2003 | 2482 | 0.040 |
Why?
|
| Gene Deletion | 1 | 1999 | 353 | 0.030 |
Why?
|
| Hydrogen Peroxide | 2 | 1989 | 173 | 0.030 |
Why?
|
| Patch-Clamp Techniques | 1 | 1999 | 381 | 0.030 |
Why?
|
| Mercuric Chloride | 1 | 1998 | 11 | 0.030 |
Why?
|
| Membrane Potentials | 1 | 1999 | 407 | 0.030 |
Why?
|
| Protein Denaturation | 1 | 1998 | 110 | 0.030 |
Why?
|
| Epidermal Growth Factor | 2 | 1999 | 116 | 0.030 |
Why?
|
| Lasers | 1 | 2018 | 105 | 0.030 |
Why?
|
| Models, Biological | 2 | 2008 | 1805 | 0.030 |
Why?
|
| Glycerol | 1 | 1998 | 35 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 1999 | 291 | 0.030 |
Why?
|
| Israel | 2 | 1988 | 68 | 0.030 |
Why?
|
| In Situ Hybridization | 2 | 2001 | 306 | 0.030 |
Why?
|
| Macromolecular Substances | 1 | 1997 | 162 | 0.030 |
Why?
|
| Aging | 1 | 2002 | 770 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 1988 | 2660 | 0.030 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2018 | 85 | 0.030 |
Why?
|
| Pyrimidines | 1 | 1999 | 414 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2018 | 269 | 0.030 |
Why?
|
| Heparin Lyase | 1 | 1996 | 4 | 0.030 |
Why?
|
| EGF Family of Proteins | 1 | 1996 | 3 | 0.030 |
Why?
|
| Polysaccharide-Lyases | 1 | 1996 | 5 | 0.030 |
Why?
|
| Heparan Sulfate Proteoglycans | 1 | 1996 | 16 | 0.030 |
Why?
|
| Polymers | 1 | 1998 | 224 | 0.030 |
Why?
|
| Amphiregulin | 1 | 1996 | 17 | 0.030 |
Why?
|
| RNA | 1 | 2000 | 595 | 0.030 |
Why?
|
| Prostate | 1 | 1999 | 434 | 0.030 |
Why?
|
| Staphylococcus aureus | 1 | 2018 | 292 | 0.030 |
Why?
|
| Kidney | 2 | 1998 | 1121 | 0.030 |
Why?
|
| Base Sequence | 2 | 2002 | 2222 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2018 | 1751 | 0.030 |
Why?
|
| Microscopy, Phase-Contrast | 2 | 1990 | 28 | 0.030 |
Why?
|
| Mitosis | 2 | 1991 | 152 | 0.020 |
Why?
|
| Acute Kidney Injury | 1 | 1998 | 360 | 0.020 |
Why?
|
| Multiplex Polymerase Chain Reaction | 1 | 2013 | 38 | 0.020 |
Why?
|
| Loss of Heterozygosity | 1 | 2013 | 85 | 0.020 |
Why?
|
| Thiocyanates | 1 | 1991 | 11 | 0.020 |
Why?
|
| Fluoresceins | 1 | 1991 | 43 | 0.020 |
Why?
|
| Binding Sites, Antibody | 1 | 1991 | 47 | 0.020 |
Why?
|
| Binding, Competitive | 1 | 1991 | 136 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2013 | 551 | 0.020 |
Why?
|
| Exons | 1 | 2013 | 452 | 0.020 |
Why?
|
| Biomarkers | 1 | 1998 | 2020 | 0.020 |
Why?
|
| Fibronectins | 1 | 1991 | 104 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 1991 | 184 | 0.020 |
Why?
|
| Antibodies, Antinuclear | 1 | 1990 | 94 | 0.020 |
Why?
|
| Cell Survival | 2 | 1989 | 1016 | 0.020 |
Why?
|
| Wolff-Parkinson-White Syndrome | 1 | 1990 | 13 | 0.020 |
Why?
|
| Monocytes | 1 | 1991 | 219 | 0.020 |
Why?
|
| Glomerulonephritis | 1 | 1990 | 80 | 0.020 |
Why?
|
| Molecular Weight | 1 | 1990 | 280 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1990 | 238 | 0.020 |
Why?
|
| Cytoplasm | 2 | 1988 | 276 | 0.020 |
Why?
|
| Endopeptidases | 1 | 1989 | 114 | 0.020 |
Why?
|
| Heart Conduction System | 1 | 1990 | 143 | 0.020 |
Why?
|
| Catheterization | 1 | 1990 | 219 | 0.020 |
Why?
|
| Mouth Neoplasms | 1 | 1991 | 223 | 0.020 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1989 | 218 | 0.020 |
Why?
|
| Hepatitis Antibodies | 1 | 1988 | 6 | 0.020 |
Why?
|
| Laser Therapy | 1 | 1990 | 149 | 0.020 |
Why?
|
| Haplorhini | 1 | 2008 | 77 | 0.020 |
Why?
|
| Hepatitis Delta Virus | 1 | 1988 | 11 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 1988 | 139 | 0.020 |
Why?
|
| Disease Progression | 2 | 2004 | 1612 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 1988 | 11031 | 0.020 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 1988 | 23 | 0.020 |
Why?
|
| Antibodies | 1 | 1990 | 349 | 0.020 |
Why?
|
| Lung Transplantation | 1 | 2013 | 390 | 0.020 |
Why?
|
| Infusions, Intra-Arterial | 1 | 1988 | 42 | 0.020 |
Why?
|
| Catalysis | 1 | 2008 | 216 | 0.020 |
Why?
|
| Cytosol | 1 | 2008 | 193 | 0.020 |
Why?
|
| Neoplasm Metastasis | 2 | 2008 | 1090 | 0.020 |
Why?
|
| Cholestasis | 1 | 1987 | 48 | 0.020 |
Why?
|
| Hepatic Artery | 1 | 1988 | 84 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 1990 | 463 | 0.020 |
Why?
|
| Endocytosis | 1 | 2008 | 187 | 0.020 |
Why?
|
| Factor VIII | 1 | 1987 | 6 | 0.020 |
Why?
|
| Hepatitis, Chronic | 1 | 1987 | 5 | 0.020 |
Why?
|
| Keratins | 1 | 1987 | 62 | 0.020 |
Why?
|
| Vimentin | 1 | 1987 | 47 | 0.020 |
Why?
|
| Histocytochemistry | 1 | 1987 | 122 | 0.020 |
Why?
|
| Ileal Diseases | 1 | 1986 | 24 | 0.020 |
Why?
|
| Cytomegalovirus Infections | 1 | 1987 | 116 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 1991 | 584 | 0.020 |
Why?
|
| Neoplasm Transplantation | 2 | 2002 | 400 | 0.010 |
Why?
|
| Postpartum Period | 1 | 1986 | 169 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2008 | 675 | 0.010 |
Why?
|
| Chronic Disease | 1 | 1988 | 988 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2013 | 2570 | 0.010 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2004 | 27 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 2 | 2002 | 1110 | 0.010 |
Why?
|
| Spinal Cord Neoplasms | 1 | 1985 | 78 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 2569 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 1991 | 1213 | 0.010 |
Why?
|
| Transplantation Immunology | 1 | 2003 | 83 | 0.010 |
Why?
|
| Stromal Cells | 1 | 2004 | 153 | 0.010 |
Why?
|
| Child, Preschool | 2 | 1988 | 4026 | 0.010 |
Why?
|
| Liver | 1 | 1987 | 1230 | 0.010 |
Why?
|
| Actin Cytoskeleton | 1 | 2004 | 201 | 0.010 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2002 | 48 | 0.010 |
Why?
|
| Cathepsin H | 1 | 2002 | 4 | 0.010 |
Why?
|
| RNA, Neoplasm | 1 | 2001 | 87 | 0.010 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group F-H | 1 | 2001 | 2 | 0.010 |
Why?
|
| Hyperplasia | 1 | 2001 | 149 | 0.010 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2001 | 21 | 0.010 |
Why?
|
| Mammary Glands, Animal | 1 | 2001 | 82 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2001 | 239 | 0.010 |
Why?
|
| Gene Library | 1 | 2001 | 126 | 0.010 |
Why?
|
| Graft vs Host Disease | 1 | 2003 | 379 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2003 | 1027 | 0.010 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2001 | 156 | 0.010 |
Why?
|
| DNA Primers | 1 | 2002 | 530 | 0.010 |
Why?
|
| Neuroblastoma | 1 | 1985 | 410 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2001 | 290 | 0.010 |
Why?
|
| Infant, Newborn | 2 | 2002 | 2544 | 0.010 |
Why?
|
| Time Factors | 2 | 2001 | 5573 | 0.010 |
Why?
|
| Biopsy | 1 | 2004 | 1224 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2002 | 894 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2001 | 583 | 0.010 |
Why?
|
| Dihydrotestosterone | 1 | 1999 | 28 | 0.010 |
Why?
|
| Tissue Extracts | 1 | 1999 | 24 | 0.010 |
Why?
|
| Cytokines | 1 | 2003 | 890 | 0.010 |
Why?
|
| Pituitary Gland | 1 | 1999 | 117 | 0.010 |
Why?
|
| In Vitro Techniques | 2 | 1991 | 945 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2001 | 1606 | 0.010 |
Why?
|
| Kidney Function Tests | 1 | 1998 | 123 | 0.010 |
Why?
|
| Kidney Tubules | 1 | 1998 | 91 | 0.010 |
Why?
|
| Regeneration | 1 | 1998 | 163 | 0.010 |
Why?
|
| Child | 1 | 1988 | 7730 | 0.010 |
Why?
|
| Prostatectomy | 1 | 1999 | 491 | 0.010 |
Why?
|
| Adolescent | 1 | 1988 | 10127 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2002 | 1717 | 0.010 |
Why?
|
| Insulin | 1 | 1999 | 1224 | 0.010 |
Why?
|
| Echocardiography | 2 | 1989 | 783 | 0.010 |
Why?
|
| Leucine | 1 | 1993 | 57 | 0.010 |
Why?
|
| Keratinocytes | 1 | 1993 | 156 | 0.010 |
Why?
|
| Thrombospondins | 1 | 1991 | 15 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1991 | 122 | 0.010 |
Why?
|
| Nephritis, Hereditary | 1 | 1990 | 5 | 0.010 |
Why?
|
| Lupus Nephritis | 1 | 1990 | 85 | 0.000 |
Why?
|
| Phonocardiography | 1 | 1989 | 3 | 0.000 |
Why?
|
| Sound | 1 | 1989 | 23 | 0.000 |
Why?
|
| Heart Septum | 1 | 1989 | 45 | 0.000 |
Why?
|
| Polyanetholesulfonate | 1 | 1989 | 1 | 0.000 |
Why?
|
| Streptolysins | 1 | 1989 | 5 | 0.000 |
Why?
|
| Glucose Oxidase | 1 | 1989 | 7 | 0.000 |
Why?
|
| Phospholipases | 1 | 1989 | 8 | 0.000 |
Why?
|
| Lysophosphatidylcholines | 1 | 1989 | 17 | 0.000 |
Why?
|
| Chromium | 1 | 1989 | 17 | 0.000 |
Why?
|
| Catalase | 1 | 1989 | 46 | 0.000 |
Why?
|
| Free Radicals | 1 | 1989 | 72 | 0.000 |
Why?
|
| Dogs | 1 | 1990 | 641 | 0.000 |
Why?
|
| Coronary Angiography | 1 | 1990 | 238 | 0.000 |
Why?
|
| Myocardial Contraction | 1 | 1989 | 193 | 0.000 |
Why?
|
| Rats, Nude | 1 | 1988 | 28 | 0.000 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 1988 | 26 | 0.000 |
Why?
|
| Microvilli | 1 | 1988 | 44 | 0.000 |
Why?
|
| Whole-Body Irradiation | 1 | 1988 | 70 | 0.000 |
Why?
|
| alpha-Fetoproteins | 1 | 1988 | 48 | 0.000 |
Why?
|
| Intercellular Junctions | 1 | 1988 | 69 | 0.000 |
Why?
|
| Bile Ducts | 1 | 1987 | 62 | 0.000 |
Why?
|
| Heart Atria | 1 | 1989 | 255 | 0.000 |
Why?
|
| Diseases in Twins | 1 | 1987 | 64 | 0.000 |
Why?
|
| Heart | 1 | 1990 | 527 | 0.000 |
Why?
|
| Angiography | 1 | 1987 | 194 | 0.000 |
Why?
|
| Myocardium | 1 | 1990 | 578 | 0.000 |
Why?
|
| Fibrosis | 1 | 1987 | 234 | 0.000 |
Why?
|
| Mice, Nude | 1 | 1988 | 830 | 0.000 |
Why?
|
| Infant, Premature | 1 | 1987 | 306 | 0.000 |
Why?
|
| Infant | 1 | 1987 | 3348 | 0.000 |
Why?
|